Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
Although testosterone levels and muscle mass decline with age, many older men have serum testosterone level in the normal range, leading to speculation about whether older men are less sensitive to testosterone. We determined the responsiveness of androgen-dependent outcomes to graded testosterone doses in older men and compared it to that in young men. The participants in this randomized, double-blind trial were 60 ambulatory, healthy, older men, 60-75 yr of age, who had normal serum testosterone levels. Their responses to graded doses of testosterone were compared with previous data in 61 men, 19-35 yr old. The participants received a long-acting GnRH agonist to suppress endogenous testosterone production and 25, 50, 125, 300, or 600 mg testosterone enanthate weekly for 20 wk. Fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, hormone levels, and safety measures were evaluated before, during, and after treatment. Of 60 older men who were randomized, 52 completed the study. After adjusting for testosterone dose, changes in serum total testosterone (change, -6.8, -1.9, +16.1, +49.5, and +101.9 nmol/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) and hemoglobin (change, -3.6, +9.9, +20.9, +12.6, and +29.4 g/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) levels were dose-related in older men and significantly greater in older men than young men (each P < 0.0001). The changes in FFM (-0.3, +1.7, +4.2, +5.6, and +7.3 kg, respectively, in five ascending dose groups) and muscle strength in older men were correlated with testosterone dose and concentrations and were not significantly different in young and older men. Changes in fat mass correlated inversely with testosterone dose (r = -0.54; P < 0.001) and were significantly different in young vs. older men (P < 0.0001); young men receiving 25- and 50-mg doses gained more fat mass than older men (P < 0.0001). Mood and visuospatial cognition did not change significantly in either group. Frequency of hematocrit greater than 54%, leg edema, and prostate events were numerically higher in older men than in young men. Older men are as responsive as young men to testosterone's anabolic effects; however, older men have lower testosterone clearance rates, higher increments in hemoglobin, and a higher frequency of adverse effects. Although substantial gains in muscle mass and strength can be realized in older men with supraphysiological testosterone doses, these high doses are associated with a high frequency of adverse effects. The best trade-off was achieved with a testosterone dose (125 mg) that was associated with high normal testosterone levels, low frequency of adverse events, and significant gains in fat-free mass and muscle strength.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are conflicting data on the effect of testosterone supplementation on muscle strength and function50,51,357,414.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [414]
In the citing paper
“Testosterone has a dose-dependent impact on fat-free mass in both the young and old, with higher levels associated with reduction in fat mass and increase in skeletal muscle mass and strength [43].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [43]
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Self-citationAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 7×
“The characteristics of young men have been described previously (29).”
BackgroundMethodResultInfluentialSelf-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Hughes, V. A., Frontera, W. R., Wood, M., Evans, W. J., Dallal, G. E., Roubenoff, R., & Singh, M. A. F. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.b209 · Cited by 921
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Cited by
Items 301–400 of 554
Sattler, F. R. (2014) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000159 · Cited by 19
“Based on results of our prior studies and those of others [18,25,26], it is unclear why testosterone supplementation produces larger reductions in fat mass up to 6-7 kg in some men with very little change in other men.”
BackgroundResultJoint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Ries, A. L., Bauldoff, G. S., Carlin, B. W., Casaburi, R. H., Emery, C. F., Mahler, D. A., Make, B. J., Rochester, C. L., ZuWallack, R., & Herrerias, C. T. (2007) · Cited by 20
Self-citationGlobal spatial patterns of infectious diseases and human evolution
Guégan, J., Prugnolle, F., & Thomas, F. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0002 · Cited by 17
Varanoske, A. N., Margolis, L. M., & Pasiakos, S. M. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa090 · Cited by 22
“Previous dose-response studies demonstrate that a given T dose results in greater serum T elevations in older (60-75 years) versus younger (1835 years) eugonadal males, but the greater increases in serum T in older males did not result in greater increases in FFM [22, 23].”
BackgroundResultInfluentialKoella, J. C., & Turner, P. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0017 · Cited by 18
Unwalla, R. J., Mousseau, J. J., Fadeyi, O., Choi, C., Parris, K. D., Hu, B., Kenney, T. F., Chippari, S. M., McNally, C., Vishwanathan, K., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00373 · Cited by 17
Exercise to Reduce Obesity in SCI
Nash, M. S., & Gater, D. R. (2007) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1204-76 · Cited by 19
Intimate relations: Evolutionary conflicts of pregnancy and childhood
Haig, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0006 · Cited by 19
Low testosterone in ageing men: a modifiable risk factor for frailty?
O’Connell, M. D. L., Ravindrarajah, R., Tajar, A., & Wu, F. C. W. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.08.003 · Cited by 16
Phenotypes of Obesity: How it Impacts Management
Shah, M., Hurt, R. T., & Mundi, M. S. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0598-1 · Cited by 17
Selective Loss of Levator Ani and Leg Muscle Volumes in Men Undergoing Androgen Deprivation Therapy
Cheung, A. S., Cunningham, C., Ko, D., Ly, V., Gray, H. A., Hoermann, R., Strauss, B. J., Hassan, E. B., Duque, G., Ebeling, P. R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01954 · Cited by 17
Neto, W. K., Silva, W. D. A., Ciena, A. P., Nucci, R. A. B., Anaruma, C. A., & Gama, E. F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00205 · Cited by 16
“…many publications have demonstrated a significant dose-dependent increase in strength andmuscle mass, myofibers cross-sectional area (CSA) enlargement, myonuclei and satellite cells aggregation in the muscles of the elderly (Bhasin et al., 2005; Sinha-Hikim et al., 2006; Sattler et al., 2011).”
BackgroundNeto, W. K., Silva, W. D. A., Ciena, A. P., Bocalini, D. S., Nucci, R. A. B., Anaruma, C. A., & Gama, E. F. (2017) · The Aging Male · doi:10.1080/13685538.2017.1365832 · Cited by 19
“Being elderly as responsive to graded doses of exogenous testosterone as young people [24].”
BackgroundDrug discovery and development for ageing: opportunities and challenges
Evans, W. J. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0287 · Cited by 23
Daabis, R. G. A., Naguib, R., Hassan, M. M., & Khalil, G. I. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.01.002 · Cited by 15
“This finding added more confusion to the available conflicting results.(2,22,35,36) The explanation of these contradictory results regarding the effect of hypodonadism on muscle weakness is not clear; moreover the studies who found a correlation between the testosterone level and the degree of muscle weakness did not…”
ResultThe aging male – diagnosis and therapy of late‐onset hypogonadism
Schreiber, G., & Ziemer, M. (2008) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2008.06493.x · Cited by 14
Nutritional Considerations in Preventing Muscle Atrophy.
Crețoiu, S., & Zugravu, C. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-1435-3_23 · Cited by 11
Gagliano‐Jucá, T., Tang, E., Bhasin, S., Pencina, K. M., Anderson, S. W., Jara, H. J., Li, Z., Melamud, K., Coleman, S. L., Aakil, A., et al. (2017) · Andrology · doi:10.1111/andr.12392 · Cited by 17
“These doses were based on dose-response studies in healthy men (Bhasin et al., 2001, 2005).”
MethodSelf-citationChasland, L. C., Knuiman, M. W., Divitini, M., Murray, K., Handelsman, D. J., Flicker, L. A., Hankey, G. J., Almeida, O. P., Golledge, J., Ridgers, N. D., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13905 · Cited by 15
Winters, S. J., Wang, C., & The Fortigel Study Group (2010) · Journal of Andrology · doi:10.2164/jandrol.109.009035 · Cited by 16
Higuchi, R. I., Thompson, A. W., Chen, J., Caferro, T. R., Cummings, M. L., Deckhut, C. P., Adams, M. E., Tegley, C. M., Edwards, J. P., López, F. J., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.034 · Cited by 17
Growth Hormone and Testosterone: Effects on Whole Body Metabolism and Skeletal Muscle in Adolescence
Mauras, N. (2006) · Hormone Research in Paediatrics · doi:10.1159/000096622 · Cited by 17
The role of iron in mediating testosterone's effects on erythropoiesis in mice
Guo, W., Ghayda, R. A., Schmidt, P. J., Fleming, M. D., & Bhasin, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000920rr · Cited by 14
Self-citationDiagnosis of hypogonadism in ageing men
Kaufman, J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09763-4 · Cited by 20
Yang, S., Dong, Z., Zhao, J., Yuan, L., Xiao, Y., Luo, X., Zhao, Z., Kang, X., Tang, K., Chen, M., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1369331 · Cited by 18
Perturbation of the Hematopoietic Profile by Anabolic Androgenic Steroids
Mullen, J., Gårevik, N., Schulze, J. J., Rane, A., Bergman, L. B., & Ekström, L. (2014) · Journal of Hormones · doi:10.1155/2014/510257 · Cited by 17
“Even though it is well known that testosterone increases hematocrit and hemoglobin during testosterone replacement therapy [18, 19] there are few studies investigating how supraphysiological doses of testosterone and other AAS such as those used in doping affect the hematological system.”
BackgroundGagliano‐Jucá, T., Storer, T. W., Pencina, K. M., Travison, T. G., Li, Z., Huang, G. T.-W., Hettwer, S., Dahinden, P., Bhasin, S., & Basaria, S. S. (2017) · Andrology · doi:10.1111/andr.12424 · Cited by 14
“5 nmol/L (DELFIA, Wallac, Turku, Finland) (Bhasin et al., 2005; Basaria et al., 2010).”
InfluentialSelf-citationBenefits and Risks of Testosterone Treatment of Older Men with Hypogonadism
Galbiati, F., Goldman, A. L., Gattu, A. K., Guzelce, E. C., & Bhasin, S. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.011 · Cited by 16
Self-citationFunctional significance of MHC variation in mate choice, reproductive outcome, and disease risk
Loisel, D. A., Alberts, S. C., & Ober, C. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0008 · Cited by 15
Ovarian sex steroid receptors and sex hormones in androgenized rats
Simão, V. A., Chuffa, L. G. D. A., & Camargo, I. C. C. (2016) · Reproduction · doi:10.1530/rep-16-0233 · Cited by 14
Testosterone treatment of hypogonadal men participating in competitive sports
Gooren, L. J., & Behre, H. M. (2008) · Andrologia · doi:10.1111/j.1439-0272.2008.00838.x · Cited by 14
“The authors were able to demonstrate that testosterone has a steeply dose-dependent effect on muscle mass and strength irrespective of gonadal status (Bhasin et al., 1996, 1997, 2001, 2005; Storer et al., 2003; Woodhouse et al., 2003).”
BackgroundUnraveling Androgen Action in Muscle: Genetic Tools Probing Cellular Mechanisms
MacLean, H. E., & Handelsman, D. J. (2009) · Endocrinology · doi:10.1210/en.2009-0438 · Cited by 18
Kim, J. W. (2020) · Korean journal of urology · doi:10.4111/icu.2020.61.3.242 · Cited by 13
“The results were not duplicated in the older group, with baseline serum PSA levels varying more drastically in this case [25].”
BackgroundMethodInfluentialAndrogenic Steroids Use and Abuse
Thirumalai, A., & Anawalt, B. D. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.008 · Cited by 21
Haider, A., Gooren, L. J., Padungtod, P., & Saad, F. (2010) · Andrologia · doi:10.1111/j.1439-0272.2009.01016.x · Cited by 14
“…of the benefit of androgen treatment on multiple target organs of hypogonadal men, and recent studies show short-term beneficial effects of testosterone in older men that are similar to those in younger men (Swerdloff & Wang, 2003; Bhasin et al., 2005; Page et al., 2005; Allan et al., 2008).”
ResultTestosterone and Body Composition in Men after Treatment for Rectal Cancer
Buchli, C., Tapper, J., Bottai, M., Holm, T., Arver, S., Blomqvist, L., & Martling, A. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12751 · Cited by 13
Abildgaard, J., Petersen, J. H., Bang, A. K., Aksglæde, L., Christiansen, P., Juul, A., & Jørgensen, N. (2021) · Andrology · doi:10.1111/andr.13124 · Cited by 13
Birzniece, V., Umpleby, A. M., Poljak, A., Handelsman, D. J., & Ho, K. K. Y. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0406 · Cited by 13
The Illusory Case for Treatment of an Invented Disease
Handelsman, D. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.682620 · Cited by 12
Han, S., Jeon, Y., Lee, T. Y., Park, G., Park, S., & Kim, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-27182-y · Cited by 14
Androgen effects on the skeletal muscle
Bhasin, S., Jasuja, R., Serra, C., Singh, R., Storer, T. W., Guo, W., Travison, T. G., & Basaria, S. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.010 · Cited by 14
Self-citationA half-century of anabolic steroids in sport
Bowers, L. D., Clark, R. V., & Shackleton, C. H. L. (2009) · Steroids · doi:10.1016/j.steroids.2009.01.007 · Cited by 18
Girard, D., Marino, F. E., & Cannon, J. (2013) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12084 · Cited by 12
“Epidemiology studies have demonstrated that testosterone and physical activity are predictors of muscle strength (Baumgartner et al., 1999), with higher testosterone levels significantly correlated with higher muscle strength in older men (Bhasin et al., 2005).”
BackgroundCasaburi, R. H., Nakata, J., Bistrong, L., Torres, E., Rambod, M., & Pórszász, J. (2015) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.3.1.2015.0128 · Cited by 14
Self-citationRossetti, M. L., Tomko, R. J., & Gordon, B. S. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03963-9 · Cited by 13
Androgen receptor is expressed in both X- and Y-carrier human spermatozoa
Zuccarello, D., Garolla, A., Ferlin, A., Menegazzo, M., Toni, L. D., Carraro, M., Veronese, C., & Foresta, C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.040 · Cited by 12
Human genetic variation of medical significance
Kídd, K. K., & Kidd, J. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0005 · Cited by 11
Management of male obesity-related secondary hypogonadism: A clinical update
Shenoy, M. T., Mondal, S., Fernandez, C. J., & Pappachan, J. M. (2024) · World Journal of Experimental Medicine · doi:10.5493/wjem.v14.i2.93689 · Cited by 14
“In a study on 161 men with LOH, the total and LDL cholesterol declined significantly, with no significant changes in HDL cholesterol and TG[56].”
McKee, A. M., & Morley, J. E. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.06.006 · Cited by 14
Seal, L. (2017) · Palgrave Macmillan UK eBooks · doi:10.1057/978-1-137-51053-2_10 · Cited by 13
Potluri, T., Taylor, M. J., Stulberg, J. J., Lieber, R. L., Zhao, H., & Bulun, S. E. (2022) · JCI Insight · doi:10.1172/jci.insight.152011 · Cited by 14
Functional capacity, sarcopenia, and bone health
Laskou, F., Patel, H. P., Cooper, C. C., & Dennison, E. M. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101756 · Cited by 17
Testosterone treatment in elderly men
Srinivas-Shankar, U., & Sharma, D. (2009) · Advances in Therapy · doi:10.1007/s12325-008-0137-4 · Cited by 12
Cardiometabolic risks during anabolic hormone supplementation in older men
He, J., Bhasin, S., Binder, E. F., Yarasheski, K. E., Castaneda‐Sceppa, C., Schroeder, E. T., Roubenoff, R., Chou, C.-P., Azen, S. P., & Sattler, F. R. (2013) · Obesity · doi:10.1002/oby.20081 · Cited by 12
“9% in low, medium, and high level pools) (30) at Boston University.”
BackgroundSelf-citationWu, B. W., Berger, M., Sum, J. C., Hatch, G. F. R., & Schroeder, E. T. (2014) · BMC Surgery · doi:10.1186/1471-2482-14-102 · Cited by 11
“However, additional studies show that the effects in males will still exist with supraphysiologic doses [48,53,54] and we expect an effect to be measured independent of age or race.”
BackgroundResultUnraveling the Paradoxical Action of Androgens on Muscle Stem Cells.
Seo, J., Kim, J.-H., & Kong, Y. (2019) · PubMed Central · doi:10.14348/molcells.2019.0004 · Cited by 16
“Cells 2019; 42(2): 97-103 muscle atrophy (Bhasin et al., 2005; Serra et al., 2013; Sih et al., 1997; Urban et al., 1995; Wilkinson et al., 2018).”
BackgroundHypogonadal Hypogonadism and Osteoporosis in Men
Romeo, J. H., & Ybarra, J. (2007) · Nursing Clinics of North America · doi:10.1016/j.cnur.2006.11.004 · Cited by 12
Determinants of GH-releasing hormone and GH-releasing peptide synergy in men
Veldhuis, J. D., & Bowers, C. Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91001.2008 · Cited by 12
“This postulate would be consistent with dose-response studies showing age-comparable effects of T on skeletal muscle (5).”
ResultSelective androgen receptor modulators: a critical appraisal
Bond, P., Smit, D. L., Verdegaal, T. J., & de Ronde, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1634799 · Cited by 11
Yang, H. J., Kim, K. H., Kim, D. S., Lee, C. H., Jeon, Y. S., Shim, S. R., & Kim, J. H. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.220171 · Cited by 13
“Additionally, several studies have found significant biochemical and physical effects (fat mass reduction and lean body-mass gain, and hormone-related improvement in quality of life) when testosterone replacement is used [21,23,53].”
Testosterone Therapy in Older Men: Present and Future Considerations
Yeap, B. B., Tran, C., Douglass, C. M., & McNeil, J. J. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01209-1 · Cited by 11
“Testosterone is an anabolic agent which increases muscle mass and strength in younger and older men [72].”
Fenton, J. M., King, J. A., Hoekstra, S. P., Valentino, S. E., Phillips, S. M., & Goosey-Tolfrey, V. L. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2063420 · Cited by 11
Valderrábano, R. J., Pencina, K. M., Storer, T. W., Reid, K. F., Kibel, A. S., Burnett, A. L. “., Huang, G. T.-W., Dorff, T. B., Privat, F., Ghattas, C., et al. (2022) · Andrology · doi:10.1111/andr.13299 · Cited by 10
Self-citationIntroducing Evolutionary Thinking For Medicine
Stearns, S. C., Nesse, R. M., & Haig, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0001 · Cited by 18
Bhasin, S., Apovian, C. M., Travison, T. G., Pencina, K. M., Huang, G. T.-W., Moore, L. L., Campbell, W. W., Howland, A., Chen, R., Singer, M. R., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.05.004 · Cited by 9
“DXA scans were all read by the same personnel at the Bone Unit of Brigham and Women’s Hospital.”
MethodInfluentialSelf-citationRelative testosterone deficiency in older men: clinical definition and presentation
Liu, P. Y., Swerdloff, R. S., & Wang, C. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.003 · Cited by 5
“The speculation that older men are more prone to adverse effects of testosterone treatment (in particular prostate disease, raised hematocrit, and fluid retention) has been confirmed directly [16].”
BackgroundResultThirumalai, A., Rubinow, K. B., Cooper, L. A., Amory, J. K., Marck, B. T., Matsumoto, A. M., & Page, S. T. (2017) · Clinical Endocrinology · doi:10.1111/cen.13342 · Cited by 9
Gonadal Steroids in Regeneration and Repair of Neuromuscular Systems
Foecking, E. M., Fargo, K. N., Brown, T. J., Sengelaub, D. R., & Jones, K. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801732-6.00008-2 · Cited by 9
Piantadosi, C., Visvanathan, R., Naganathan, V., Hunter, P., Cameron, I. D., Lange, K. M., Karnon, J. D., & Chapman, I. M. (2011) · BMC Geriatrics · doi:10.1186/1471-2318-11-66 · Cited by 10
“In addition, it has been shown to increase muscle strength, albeit modestly and variably, more with high doses and in men with low testosterone levels [20,22,23].”
BackgroundSingle-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
Tacey, A., Parker, L., Yeap, B. B., Joseph, J., Lim, E. M., GARNHAM, A. P., Hare, D. L., Brennan‐Speranza, T. C., & Levinger, I. (2019) · Endocrine Connections · doi:10.1530/ec-18-0473 · Cited by 11
Muscle Insulin Resistance Elicits Muscle Atrophy in Obesity
Razi, O., Zamani, N., Saeidi, A., Hadjicharalambous, M., Ayed, K., Hackney, A. C., Coso, J. D., Laher, I., Muscogiuri, G., & Zouhal, H. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00672-6 · Cited by 13
“…with the majority being related to lifestyle (weight loss, physical activity, a comation of weight loss and exercise, nutritional modifica - tions) [43, 44], pharmacological (Mst inhibitors) [45], and hormonal (testosterone, GH, and insulin-like growth factor-1 [IGF-1]) [46, 47] interventions.”
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01512-z · Cited by 9
“Background Anabolic Androgenic Steroids (AAS) increase fat free mass, muscle size and strength in men [1, 2] with the majority of hypertrophic effects mediated through the Androgen Receptor (AR) [3] which induces a genomic mode of action by modulating transcription [4].”
BackgroundCai, J., Yue, J., Lu, N., Li, S., Zheng, J., Huang, R., Jiang, Y., Shan, C., Liu, W., Ma, J., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020483 · Cited by 9
A Content Analysis of Testosterone Websites: Sex, Muscle, and Male Age-Related Thematic Differences
Ivanov, N., Vuong, J., & Gray, P. B. (2017) · American Journal of Men s Health · doi:10.1177/1557988317734667 · Cited by 9
“Supraphysiological doses of testosterone, combined with strength training, increase fat-free mass, muscle size, and strength in normal young and older men (Bhasin et al., 2005; 1996).”
BackgroundVaranoske, A. N., Harris, M. N., Hebert, C., Howard, E. E., Johannsen, N. M., Heymsfield, S. B., Greenway, F. L., Margolis, L. M., Lieberman, H. R., Beyl, R. A., et al. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00190.2022 · Cited by 10
Χατζηδημητρίου, Κ., Gougoura, S. G., Bargiota, Α., & KOUKOULIS, G. N. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.03.001 · Cited by 8
“The administered testosterone-induced reduction of visceral and total-body fat mass in young [29] and older men [34] and of circulating adiponectin concentrations in hypogonadal [7,14,35] and eugonadal [15] men may indicate an influence of testosterone on the secretion and/or metabolism of adiponectin in a way that se…”
BackgroundEffects of varying doses of testosterone on atherogenic markers in healthy younger and older men
Roberts, C. K., Chen, B. H., Pruthi, S., & Lee, M. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00372.2013 · Cited by 8
Self-citationLate-onset male hypogonadism and testosterone replacement therapy in primary care.
Brunton, S., & Sadovsky, R. (2010) · PubMed · Cited by 9
Rastrelli, G., & Forti, G. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_31-1 · Cited by 8
Osteosarcopenia: pathogenesis, diagnosis and therapeutic approaches
Grebennikova, T. A., Тамерланович, Ц. Т., Vorobeva, J. R., & Belaya, Z. E. (2020) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1243 · Cited by 9
Anabolic Interventions in ESRD
Storer, T. W. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2009.08.008 · Cited by 8
Self-citationSaad, F., Haider, A., Giltay, E. J., & Gooren, L. J. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.081 · Cited by 7
Performance Enhancing Hormones in Sports Doping
Handelsman, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00024-x · Cited by 16
Evolutionary biology as a foundation for studying aging and aging-related disease
Ackermann, M., & Pletcher, S. D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0018 · Cited by 7
Caliber, M., & Hackett, G. I. (2019) · The Aging Male · doi:10.1080/13685538.2018.1549211 · Cited by 7
“Notably, there was no MACE (Major Adverse Cardiovascular Events) reported [19].”
BackgroundResultInfluentialReproductive and Nonreproductive Actions of Testosterone
Bhasin, S., & Jasuja, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65412-0 · Cited by 10
Self-citationReproductive endocrinology and aging in human males: An evolutionary perspective
Bribiescas, R. G. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105898 · Cited by 6
Ramasamy, R., Wilken, N., Scovell, J. M., Kovac, J. R., & Lipshultz, L. I. (2014) · Urology · doi:10.1016/j.urology.2014.07.049 · Cited by 7
Jankowska, E. A., Tkaczyszyn, M., Węgrzynowska‐Teodorczyk, K., Majda, J., von Haehling, S., Doehner, W., Banasiak, W., Anker, S. D., & Ponikowski, P. P. (2014) · ESC Heart Failure · doi:10.1002/ehf2.12002 · Cited by 6
“Further, there is evidence suggesting reduced sensitivity to testosterone effects in target tissues in older men.(36) We hypothesize that a weak but visible impact of LOH on increased long-term mortality in patients aged ≤60 years may reflect more detrimental effects of decreased circulating testosterone and associate…”
BackgroundSubcutaneous testosterone pellet therapy for reversal of male osteoporosis: a review and case report
Dorr, B., Abdelaziz, A., & Karram, M. M. (2023) · The Aging Male · doi:10.1080/13685538.2023.2181953 · Cited by 6
“In our case, the patient did not have any adverse events and a recently published 9-year study demonstrated extremely low rates of complications from subcutaneous testosterone administration TRT [18].”
BackgroundOsteoporosis in men: the role of testosterone and other sex-related factors
Kelly, J. J., & Moses, A. M. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000184293.92198.90 · Cited by 6
Rossetti, M. L., Dunlap, K. R., Salazar, G., Hickner, R. C., Kim, J., Chase, P. B., Miller, B. F., & Gordon, B. S. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111391 · Cited by 6
Recent advances in cell‐based and cell‐free therapeutic approaches for sarcopenia
Wu, S., Lin, S., Zhang, X., Alizada, M., Wang, L., Zheng, Y., Ke, Q., & Xu, J. (2022) · The FASEB Journal · doi:10.1096/fj.202200675r · Cited by 7
The population structure of pathogenic bacteria
Dykhuizen, D. E., & Kalia, A. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0014 · Cited by 9
The characteristics of late-onset hypogonadism, its prevalence, symptoms, and diagnosis
Gooren, L. J. (2006) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2006.05.005 · Cited by 6
“Threshold plasma values of testosterone for each of these functions are beginning to be established and elderly men appear as responsive to the action of testosterone as younger men [6] which is reassuring because it implies that it is worthwhile to treat androgen deficiencies in the aging male.”
Androgen Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-727-7_18 · Cited by 7
Anabolic-androgenic steroids among recreational athletes and cardiovascular risk
Meagher, S., Irwig, M. S., & Rao, P. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001235 · Cited by 15
Effect of Current and Former Anabolic-Androgenic Steroid Abuse on the Patellar Tendon
Damgaard, A., Højfeldt, G. W., Thorsgaard, O., Bulut, Y., Linden, F. H., Schjerling, P., Mackey, A. L., Kistorp, C., Magnusson, S. P., Kjær, M., et al. (2025) · The American Journal of Sports Medicine · doi:10.1177/03635465251340701 · Cited by 5
“3,4,38 Increased quadriceps strength can be accompanied by increased tendon stiffness and an increased PT CSA, underscoring that the tendon adapts to exercise-associated strain.”
Rastrelli, G., & Forti, G. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_31 · Cited by 5
Rivas, J. G., Eguibar, A., Quesada, J., Álvarez‐Maestro, M., & Carrión, D. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-84752-4_2 · Cited by 5
Metadata
- Authors
- Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., Magliano, L., & Storer, T. W.
- Affiliations
- University of California, Los Angeles (US)
- Charles R. Drew University of Medicine and Science (US)
- Washington University in St. Louis (US)
- El Camino College (US)
- Corresponding author
- Bhasin, Shalender
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-02
- Volume
- 90
- Issue
- 2
- Pages
- 678-688
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2133467178
- Cited by
- 544
- References
- 73
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 23 · 2023: 16 · 2022: 30 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 30 · 2017: 28 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 22
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34, 5u01dk054047-06)
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of General Medical Sciences (GM-00425)
- National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-54047, R01DK049296, 2R01DK49296-02A, R01DK059627)
- National Center for Research Resources (G12 RR 03026, P41-RR000954, P20RR11145, 5P41-RR-000954, G12RR003026, P20RR011145)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD041748, R01HD043348)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- older men, androgen response, skeletal muscle, fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, GnRH agonist, testosterone replacement therapy, aging, hemoglobin response, adverse effects, treatment discontinuation
- MeSH terms
- Adult, Age Factors, Aged, Aging, Energy Intake, Exercise Test, Humans, Luteinizing Hormone, Male, Middle Aged, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone, Leuprolide, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.